{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/rubella/management/non-pregnant-suspected-rubella-or-possible-exposure/","result":{"pageContext":{"chapter":{"id":"dff6856b-8ce5-59b8-911b-139c6149a61e","slug":"non-pregnant-suspected-rubella-or-possible-exposure","fullItemName":"Scenario: Non-pregnant - suspected rubella or possible exposure","depth":2,"htmlHeader":"<!-- begin field 80bb0462-ae7b-4e71-818f-2e1364d122d4 --><h2>Scenario: Non-pregnant - suspected rubella or possible exposure</h2><!-- end field 80bb0462-ae7b-4e71-818f-2e1364d122d4 -->","summary":"Covers the management of people (children, men, and women who are not pregnant) with suspected rubella, or who have been in contact with a person who has confirmed or suspected rubella.","htmlStringContent":"<!-- begin item 97518f02-e9c2-4b97-81e1-9b30050e133d --><!-- begin field 10c2905e-ddf7-4125-a142-acbc01593d4e --><p>From birth onwards.</p><!-- end field 10c2905e-ddf7-4125-a142-acbc01593d4e --><!-- end item 97518f02-e9c2-4b97-81e1-9b30050e133d -->","topic":{"id":"f4a4135e-ffdc-5df5-b074-abfbec05f014","topicId":"300947fe-8e33-4d94-bbba-f4d16a0ba0f4","topicName":"Rubella","slug":"rubella","lastRevised":"Last revised in November 2018","chapters":[{"id":"3aff984b-cc64-5eef-a912-f7704fcdd2e0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"48701a5d-fb3c-54ae-8a4d-d8ffb0b3fd08","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9fe254c0-d336-5473-8be6-d3b58967643f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"783a0842-a9d9-5ecf-aa6d-183b6bd947f8","slug":"changes","fullItemName":"Changes"},{"id":"0b45633f-1453-5f54-bd26-a5d793bb79e0","slug":"update","fullItemName":"Update"}]},{"id":"4e272831-90b9-5f58-8133-46358fd68bc3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"71613e96-82dc-56c0-a022-916278e5d473","slug":"goals","fullItemName":"Goals"},{"id":"1b880ef4-fa9c-5899-a396-74128fb2bf51","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bebe0c0e-b00e-5e4f-a9f0-bf76dc254163","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"98a30d33-4581-55fa-93c7-c24d96973f5b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a3a2016b-1d86-5856-be17-747a8db43be0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"6d487784-2b75-58e2-acd3-8542a361a149","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d0918936-370c-5c73-89bd-9f683169c2b7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"491f6f98-9648-5cc7-9db1-1e8547d3dc07","slug":"definition","fullItemName":"Definition"},{"id":"a56a3c8f-7763-5bac-b0c1-b0f8511b1c11","slug":"cause","fullItemName":"Cause"},{"id":"ec058aad-7d08-52ae-9477-590932a58a90","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0e581233-5a46-5f2e-9b25-a488f499812d","slug":"complications","fullItemName":"Complications"},{"id":"17cdeb34-85ba-5fcb-9f0d-d74a2a51bb20","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"34f907f8-e8f5-5d22-98eb-deba682bb047","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"da084fad-aad1-57b0-8b1f-779333543cf7","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9198e681-3b01-56a1-883b-f3798a6121b9","slug":"assessment","fullItemName":"Assessment"},{"id":"f9b81df6-547e-5760-9691-a9637efd7f52","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"349017cb-aa09-5c4f-9adb-c3cd0b689c57","fullItemName":"Management","slug":"management","subChapters":[{"id":"dff6856b-8ce5-59b8-911b-139c6149a61e","slug":"non-pregnant-suspected-rubella-or-possible-exposure","fullItemName":"Scenario: Non-pregnant - suspected rubella or possible exposure"},{"id":"ebcad003-eb41-5e51-b604-e5546e36c692","slug":"pregnant-suspected-confirmed-rubella-or-possible-exposure","fullItemName":"Scenario: Pregnant - suspected/confirmed rubella or possible exposure"}]},{"id":"3875c788-962e-5c7a-8996-f7f23d3d842d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"998db942-1480-55a2-b4c9-1e6857da624a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f2be8bd9-0794-52a8-a9f6-0dfa3d744111","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"670c60c7-d470-5310-9dfd-cd849cdb432d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a7436ace-aca6-5c90-9e7c-7b7a5f055024","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"741cd2cb-5dcf-5f25-bae1-8b35a0aa88ba","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b9d37643-879f-5874-a2e5-2eeda488084d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5e833736-5cb6-56ed-ac76-3dedea764334","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"349017cb-aa09-5c4f-9adb-c3cd0b689c57","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"00393c94-9f61-52ba-951c-cf8bbd324fd6","slug":"non-pregnant","fullItemName":"Non-pregnant","depth":3,"htmlHeader":"<!-- begin field 0611428d-cdb6-49b4-b3fb-4346a79bd100 --><h3>Management of suspected rubella or possible exposure in a non-pregnant person</h3><!-- end field 0611428d-cdb6-49b4-b3fb-4346a79bd100 -->","summary":null,"htmlStringContent":"<!-- begin item 574ec61c-b0d2-40ae-8f44-f8f40de2f794 --><!-- begin field 7302e181-618b-4917-a7a4-9abe544bdd01 --><p><strong>If there is clinical suspicion of rubella infection:</strong></p><ul><li><strong>Contact the local Health Protection Team (HPT) immediately.</strong><ul><li>Rubella is a notifiable disease:<ul><li>Information on <a data-hyperlink-id=\"3db78088-9fa3-432c-84ec-a9a400bc3f10\" href=\"http://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids\" target=\"_blank\">how to report a notifiable disease</a> is available from the <a data-hyperlink-id=\"bad49bac-3a96-4353-aa8b-a9a400bc3f68\" href=\"https://www.gov.uk/government/organisations/public-health-england\" target=\"_blank\">Public Health England website</a>.</li><li>Information on <a data-hyperlink-id=\"c7cae466-39c5-4968-b376-a9a400bc5123\" href=\"https://www.hps.scot.nhs.uk/resourcedocument.aspx?id=1838\" target=\"_blank\">how to report a notifiable disease in Scotland</a> is available from the <a data-hyperlink-id=\"d38565a1-e6b3-4e5c-b79e-a9a400bc51cb\" href=\"https://www.hps.scot.nhs.uk/haiic/index.aspx\">Health Protection Scotland website</a>.</li></ul></li><li>Discuss the need for testing, samples required and the testing schedule:<ul><li>An immediate oral fluid sample may be requested — if positive, further testing may be carried out for confirmatory and genotyping purposes.</li><li>Samples may also be tested for other infections which can present with similar clinical features (such as measles).</li></ul></li></ul></li><li><strong>Advise the person (or their carer):  </strong><ul><li>That rubella is usually a mild, self-limiting condition which typically resolves within a week.</li><li>That there is no specific treatment for rubella — they should rest, drink adequate fluids, and take paracetamol or ibuprofen (if appropriate) for symptomatic relief (aspirin should be avoided in children younger than 16 years of age).<ul><li>For more information on prescribing paracetamol and ibuprofen, see the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.</li></ul></li><li>To stay away from school or work for at least 5 days after the initial development of the rash.</li><li>To avoid contact with pregnant women:<ul><li>Pregnant women who develop a rash, or have been in direct contact with someone with a rash who is potentially infectious, should be advised to consult a doctor or midwife immediately.</li><li>For further information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/rubella/management/pregnant-suspected-confirmed-rubella-or-possible-exposure/\">contact with suspected or confirmed rubella in pregnancy</a>.</li></ul></li><li>To inform clinical staff of confirmed or suspected infection prior to attending medical areas, until known to be non-infectious or uninfected.</li><li>To minimise the risk of spread of infection to others by simple hygiene measures such as covering their mouth and nose with a disposable tissue and washing their hands after using or disposing of tissues.</li><li>That specific follow up of non-pregnant people with rubella is usually not necessary — complications are rare and results of tests can be relayed by phone. However, they should:<ul><li>Seek urgent medical advice if symptoms do not settle as expected or new features suggestive of <a class=\"topic-reference internal-reference\" href=\"/topics/rubella/background-information/complications/\">complications</a> of rubella develop — arrange urgent assessment in secondary care if serious complications (such as haemorrhagic complications or encephalitis) are suspected.</li></ul></li><li>To get up-to-date with their vaccinations, if applicable, once they have recovered from the acute symptoms.<ul><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li><li>Adult women of childbearing age should avoid getting pregnant for at least four weeks after receiving MMR vaccine.</li></ul></li></ul></li></ul><p><strong>If a non-pregnant person has been in contact with confirmed or suspected rubella:</strong></p><ul><li>Advise the person (or their carer) to seek medical advice if they develop symptoms — if symptoms suggestive of rubella develop, the local Health Protection Team must be contacted immediately and laboratory confirmation will be required.<ul><li>Susceptible people who have been in contact with confirmed or suspected rubella should avoid contact with pregnant women.</li></ul></li></ul><!-- end field 7302e181-618b-4917-a7a4-9abe544bdd01 --><!-- end item 574ec61c-b0d2-40ae-8f44-f8f40de2f794 -->","subChapters":[{"id":"1345eef3-0634-58f7-97ed-fa36784a51b8","slug":"basis-for-recommendation-80e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ac740a02-5293-4feb-b922-e5fcb4d53a09 --><h4>Basis for recommendation</h4><!-- end field ac740a02-5293-4feb-b922-e5fcb4d53a09 -->","summary":null,"htmlStringContent":"<!-- begin item 80ec7452-9202-46eb-9a4e-cf7ee02ab05d --><!-- begin field 8f5752b2-1456-4498-aabe-4cffd16c83d3 --><p>The recommendations on the management of suspected rubella or possible exposure in non-pregnant people are based on clinical guidelines <em>Rubella (German measles): guidance, data and analysis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2016b</a>], <em>Rubella (German Measles, Three-Day Measles)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2017</a>], <em>Health protection in schools and other childcare facilities. A practical guide for staff on managing cases of infectious diseases in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2017</a>], the World Health Organization factsheet on <em>Rubella</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">WHO, 2018</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Lambert, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">BMJ Best Practice, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bukasa, 2018</a>].</p><h5>Notification and confirmation of diagnosis</h5><ul><li>Rubella has been a notifiable disease in the UK since 1988 — health professionals have a legal obligation to report all clinically diagnosed cases. Notification should be based on clinical suspicion and should not await laboratory confirmation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bukasa, 2018</a>].</li><li>Laboratory confirmation of rubella in non-pregnant people is necessary for surveillance purposes rather than management of the individual. Detection, confirmation and classification of all suspected cases is required as part of the commitment of all member states of the World Health Organization (WHO) European Region to eliminate measles and rubella [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2018b</a>].</li></ul><h5>Management of rubella in non-pregnant people</h5><ul><li>Postnatal rubella is generally a mild self-limiting condition. No specific antiviral therapy or rubella-specific immunoglobulins are available (Human Normal Immunoglobulin is only considered appropriate in specific cases for pregnant women) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2017</a>].</li><li>Adequate fluid intake should be maintained to replace fluid loss, although there have been no controlled trials that have shown the benefit of this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Guppy et al, 2011a</a>].</li><li>Guidance from the Public Health England on Health protection in schools and other childcare facilities states that children with suspected rubella should be kept away from school or nursery for 5 days from the onset of rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2018a</a>], and this can be reasonably extrapolated to adults.</li></ul><h5>Serious complications</h5><ul><li>Complications of rubella are rare in non-pregnant people but are potentially serious [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Gershon, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Bouthry, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">BMJ Best Practice, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2018</a>].<ul><li>Bleeding disorders (thrombocytopenia) have been reported in about 1 in 3000 infections. Case reports have described bleeding into vital organs such as the eye, brain, or kidney.</li><li>Encephalitis has been reported in about 1 in 6000 cases. In a previous epidemic, encephalitis occurred in one in 5000 people and has an estimated mortality rate of 20–50%.</li><li>Other rarely occurring neurological complications that have been reported include myelitis, optic neuritis, peripheral neuritis, and Guillain-Barre syndrome.</li></ul></li></ul><h5>Promote vaccine uptake</h5><ul><li>Rubella is preventable by immunisation with 2 doses of the measles mumps rubella (MMR) vaccine — every opportunity to pick up on missed vaccines and ensure high uptake of the MMR vaccine should be taken [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2018b</a>].</li><li>Non-immune non-pregnant women should be encouraged to have their antibody status determined and undergo rubella vaccination with MMR if needed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2016a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">Dontigny, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">WHO, 2018</a>].<ul><li>The Public Health England Guidance on Immunisation (Green Book) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2013</a>] states that there is no evidence that rubella-containing vaccines are teratogenic, however, as a precaution, MMR vaccine should not be given to women known to be pregnant and if MMR vaccine is given to adult women, they should be advised to guard against pregnancy for one month.</li></ul></li></ul><h5>Contact with suspected or confirmed rubella</h5><ul><li>Guidance from Public Health England states that children with suspected rubella should be kept away from school or nursery for 5 days after the development of the rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">PHE, 2017</a>]  and this can be reasonably extrapolated to adults.</li><li>However, as people can be infectious for up to 7 days before the onset of the rash to 7-10 days after rash onset [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">HPA, 2011b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2017</a>], CKS recommends it is prudent for the affected person to avoid contact with pregnant women during this time period. Infants with CRS can transmit virus for up to 1 year after birth [<a class=\"bibliography-reference internal-reference\" href=\"/topics/rubella/references/\">CDC, 2017</a>].</li></ul><!-- end field 8f5752b2-1456-4498-aabe-4cffd16c83d3 --><!-- end item 80ec7452-9202-46eb-9a4e-cf7ee02ab05d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}